Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 29.6B | 28.6B | 29.1B | 28.3B |
Cost of revenue | 16.6B | 16.3B | 16.8B | 16.3B |
Gross profit | 13.0B | 12.3B | 12.3B | 12.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 6.2B | 6.0B | 6.1B | 5.8B |
Operating income | 2.8B | 2.4B | 2.5B | 2.5B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 124.9M | 114.9M | 116.0M | 112.4M |
Other income expense | — | — | — | — |
Pretax income | 3.1B | 2.5B | 2.7B | 2.7B |
Tax provision | 692.4M | 622.1M | 628.0M | 641.1M |
Net income | 2.5B | 1.8B | 2.0B | 2.0B |
Basic EPS | — | 13.1 | 14.4 | 14.5 |
Diluted EPS | — | 13.1 | 14.4 | 14.5 |
Basic average shares | — | 140.6M | 140.7M | 140.7M |
Diluted average shares | — | 140.6M | 140.7M | 140.7M |
EBITDA | 4.7B | 3.9B | 4.1B | 4.1B |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |